https://www.selleckchem.com/pr....oducts/aristolochic-
0001) in plasma than in PF. For the first time, we discovered that the higher level of CD4 PD-1 T cells in the circulation and the higher sPD-1 level in plasma predict poor survival of OC patients. We suggest that PD-1 could be a predictive biomarker for OC patients and successful immunotherapy. We suggest that PD-1 could be a predictive biomarker for OC patients and successful immunotherapy. Clinical studies have indicated a relationship between diabetic nephropathy (DN) and the incidence and prevalence of renal cell carcin
Like
Comment
Share
